START New York Long Island, LLC — New Hyde Park, New York

START New York Long Island, LLC is a clinical research site located in New Hyde Park, New York, United States 11042.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

START New York Long Island, LLC has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer Patients, Metastatic Castration-resistant Prostate Cancer, mCRPC.

Sponsors: K36 Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START New York Long Island, LLC?

START New York Long Island, LLC has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START New York Long Island, LLC conducted?

START New York Long Island, LLC has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer Patients, Metastatic Castration-resistant Prostate Cancer, mCRPC.

Is START New York Long Island, LLC accredited by Crixeo Health?

START New York Long Island, LLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START New York Long Island, LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.